Viral persistence in neurons explained by lack of major histocompatibility class I expression.

Viruses frequently persist in neurons, suggesting that these cells can evade immune surveillance. In a mouse model, 5 x 10(6) cytotoxic T lymphocytes (CTLs), specific for lymphocytic choriomeningitis virus (LCMV), did not lyse infected neurons or cause immunopathologic injury. In contrast, intracerebral injection of less than 10(3) CTL caused disease and death when viral antigens were expressed on leptomeningeal and choroid plexus cells of the nervous system. The neuronal cell line OBL21 expresses little or no major histocompatibility (MHC) class I surface glycoproteins and when infected with LCMV, resisted lysis by virus-specific CTLs. Expression of MHC heavy chain messenger RNA was limited, but beta 2-microglobulin messenger RNA and protein was made normally. OBL21 cells were made sensitive to CTL lysis by transfection with a fusion gene encoding another MHC class I molecule. Hence, neuronal cells probably evade immune surveillance by failing to express MHC class I molecules.

[1]  M. Oldstone,et al.  Generation of a functional cDNA encoding the LdH2 class-I molecule by using a single-LTR retroviral shuttle vector. , 1991, Gene.

[2]  J. Monaco,et al.  MHC class II region encoding proteins related to the muKidrug resistance family of transmembrane transporters , 1990, Nature.

[3]  J. Monaco,et al.  Transport protein genes in the murine MHC: possible implications for antigen processing. , 1990, Science.

[4]  S. Beck,et al.  Sequences encoded in the class II region of the MHC related to the 'ABC' superfamily of transporters , 1990, Nature.

[5]  R. Demars,et al.  A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway , 1990, Nature.

[6]  P. Parham Peptide feeding and cellular cookery , 1990, Nature.

[7]  C. Cepko,et al.  Establishment and characterization of multipotent neural cell lines using retrovirus vector-mediated oncogene transfer. , 1990, Journal of neurobiology.

[8]  J. Whitton,et al.  Molecular analyses of a five-amino-acid cytotoxic T-lymphocyte (CTL) epitope: an immunodominant region which induces nonreciprocal CTL cross-reactivity , 1989, Journal of virology.

[9]  M. Oldstone,et al.  Efficiency and effectiveness of cloned virus-specific cytotoxic T lymphocytes in vivo. , 1989, Journal of Immunology.

[10]  H. Ljunggren,et al.  Association of class I major histocompatibility heavy and light chains induced by viral peptides , 1989, Nature.

[11]  D L Alkon,et al.  Memory storage and neural systems. , 1989, Scientific American.

[12]  J. D. Young,et al.  IN VIVO EXPRESSION OF PERFORIN BY CD8+ LYMPHOCYTES DURING AN ACUTE VIRAL INFECTION BY LUCY , 1989 .

[13]  P. Dellabona,et al.  Transcriptional control of MHC class II gene expression during differentiation from B cells to plasma cells. , 1989, Journal of immunology.

[14]  E. Appella,et al.  Developmental and tissue-specific expression of nuclear proteins that bind the regulatory element of the major histocompatibility complex class I gene , 1989, The Journal of experimental medicine.

[15]  S. Jonjić,et al.  Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4+ T lymphocytes , 1989, The Journal of experimental medicine.

[16]  D. Moskophidis,et al.  Recovery from Acute Virus Infection , 1988, Annals of the New York Academy of Sciences.

[17]  J. Whitton,et al.  Fine dissection of a nine amino acid glycoprotein epitope, a major determinant recognized by lymphocytic choriomeningitis virus-specific class I-restricted H-2Db cytotoxic T lymphocytes , 1988, The Journal of experimental medicine.

[18]  F. Bloom,et al.  Viral infection of neurons can depress neurotransmitter mRNA levels without histologic injury , 1988, Brain Research.

[19]  J. Whitton,et al.  Molecular definition of a major cytotoxic T-lymphocyte epitope in the glycoprotein of lymphocytic choriomeningitis virus , 1988, Journal of virology.

[20]  S. de la Luna,et al.  Efficient transformation of mammalian cells with constructs containing a puromycin-resistance marker. , 1988, Gene.

[21]  A. Israël,et al.  A common positive trans-acting factor binds to enhancer sequences in the promoters of mouse H-2 and beta 2-microglobulin genes. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[22]  H. Lassmann,et al.  Cellular immune reactivity within the CNS , 1986, Trends in Neurosciences.

[23]  M. Oldstone,et al.  Cytoimitiunotherapy for persistent virus infection reveals a unique clearance pattern from the central nervous system , 1986, Nature.

[24]  R. Flavell,et al.  Beta 2-microglobulin is not required for cell surface expression of the murine class I histocompatibility antigen H-2Db or of a truncated H-2Db. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[25]  A. McMichael,et al.  The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides , 1986, Cell.

[26]  P. Herrlich,et al.  Interferon-gamma, mitomycin C, and cycloheximide as regulatory agents of MHC class II-associated invariant chain expression. , 1986, Journal of immunology.

[27]  M. Oldstone,et al.  Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus in vivo , 1984, Journal of virology.

[28]  K. Ozato,et al.  MONOCLONAL ANTIBODIES TO MOUSE MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGENS: IV. A SERIES OF HYBRIDOMA CLONES PRODUCING ANTI‐H-2d ANTIBODIES AND AN EXAMINATION OF EXPRESSION OF H‐2d ANTIGENS ON THE SURFACE OF THESE CELLS , 1982, Transplantation.

[29]  P. A. Peterson,et al.  Role of beta2-microglobulin in the intracellular processing of HLA antigens. , 1981, Biochemistry.

[30]  K. Ozato,et al.  Monoclonal antibodies to mouse MHC antigens. II. Antibodies to the H-2Ld antigen, the products of a third polymorphic locus of the mouse major histocompatibility complex. , 1980, Journal of immunology.

[31]  R. Johnson,et al.  Selective vulnerability of neural cells to viral infections. , 1980, Brain : a journal of neurology.

[32]  H. Lemke,et al.  Fine Specificity Analysis with Monoclonal Antibodies of Antigens Controlled by the Major Histocompatibility Complex and by the Qa/TL Region in Mice , 1979, Immunological Reviews.

[33]  C. Barnstable,et al.  The genetic control of HLA-A and B antigens in somatic cell hybrids: requirement for beta2 microglobulin. , 1978, Tissue antigens.

[34]  R. Zinkernagel,et al.  Antiviral protection by virus-immune cytotoxic T cells: infected target cells are lysed before infectious virus progeny is assembled , 1977, The Journal of experimental medicine.

[35]  N. Nathanson,et al.  IMMUNOPATHOGENESIS OF ACUTE CENTRAL NERVOUS SYSTEM DISEASE PRODUCED BY LYMPHOCYTIC CHORIOMENINGITIS VIRUS , 1972, The Journal of experimental medicine.

[36]  M. Oldstone,et al.  PATHOGENESIS OF CHRONIC DISEASE ASSOCIATED WITH PERSISTENT LYMPHOCYTIC CHORIOMENINGITIS VIRAL INFECTION , 1970, The Journal of experimental medicine.

[37]  K. Rock,et al.  Reassociation with beta 2-microglobulin is necessary for Db class I major histocompatibility complex binding of an exogenous influenza peptide. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[38]  W. Fiers,et al.  Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA-A,B antigens in vascular endothelial cells and dermal fibroblasts in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[39]  G. Wong,et al.  Inducible expression of H–2 and Ia antigens on brain cells , 1984, Nature.

[40]  G. Wong,et al.  Effect of cloned interferon‐γ on expression of H‐2 and Ia antigens on cell lines of hemopoietic, lymphoid, epithelial, fibroblastic and neuronal origin , 1984, European journal of immunology.